In 2023, the respiratory system medicine sales in the UK were a certain percentage of total sales (exact figure not provided). The forecast for 2024-2028 indicates a consistent year-on-year decline, with percentages dropping from 7% in 2024 to 6.3% by 2028. This represents a decreasing trend over five years with a CAGR that highlights a slow but steady contraction in market share over the period.

Future trends to watch for include:

The impact of new respiratory therapies and technological innovations on market dynamics.
Potential policy changes affecting NHS budget allocations and respiratory care funding.
Shifts in consumer behavior towards preventative health measures and telemedicine solutions.